Nature: outbreak underscores absence of licensed hantavirus vaccine, decade-plus development timeline

Nature news article (d41586-026-01494-9) reviews the lack of a licensed hantavirus vaccine globally as the MV Hondius cluster brings new attention. Highlights Jay Hooper (USAMRIID) Phase 1 ANDV DNA-vaccine work showing neutralizing antibody induction in humans, but warns clinical development to licensure could take a decade or more without major federal funding. Frames vaccine gap as systemic biodefense issue.

Cases

—

Deaths

—

Author

—

Disease

hantavirus